You are using an outdated browser. Please upgrade your browser to improve your experience.

autoimmune lymphoproliferative syndrome type 2A

Disease Summary
Associated Targets (1)
Tchem

1


Mondo Description A rare, primary immunodeficiency with an autosomal dominant pattern of inheritance but incomplete penetrance. It is caused by a mutation in the CASP10 (caspase-10) gene that leads to defective Fas-induced apoptosis. Disruption of Fas-induced apoptosis impairs lymphocyte homeostasis and immune tolerance. Characteristic laboratory findings include an increase in circulating, double-negative (CD4-/CD8-) T cells in the setting of immune-mediated anemia, thrombocytopenia and neutropenia. Clinical signs present in childhood include fatigue, pallor, bruising, hepatosplenomegaly and chronic, non-malignant, non-infectious lymphadenopathy. The clinical course is influenced by a strong association with other autoimmune disorders and an increased risk for developing Hodgkin and non-Hodgkin lymphoma.
Uniprot Description A disorder of apoptosis that manifests in early childhood and results in the accumulation of autoreactive lymphocytes. It is characterized by non-malignant lymphadenopathy with hepatosplenomegaly, and autoimmune hemolytic anemia, thrombocytopenia and neutropenia.
Mondo Term and Equivalent IDs
MONDO:0011383:  autoimmune lymphoproliferative syndrome type 2A
MESH:C565833: 
NCIT:C39576: 
UMLS:C1519709: 
UMLS:C1858968: